SEC Form 4 · accession 0001232524-18-000025
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce C Cozadd
Officer — Chairman & CEO · Director
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 26, 2018 | F | 6,269 | $147.44 | D | 267,468 | D | |
| Ordinary Shares | Feb 27, 2018 | F | 3,638 | $143.80 | D | 263,830 | D | |
| Ordinary Shares | Feb 28, 2018 | S | 1,000 | $150.00 | D | 262,830 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.